Invivyd, INC Schedule 13G passive stakes

RA Capital Management and its affiliates report a 7% beneficial ownership stake in Invivyd, Inc. through pre-funded warrants.

Maverick Capital, Ltd. and its affiliates have filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in Invivyd, Inc. as of December 31, 2025.

Soleus Capital Management and affiliated entities report a combined 2.8% passive beneficial ownership in Invivyd, Inc. common stock.

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have disclosed a 7.9% beneficial ownership stake in INVIVYD, INC., totaling 21,785,166 shares.

Point72 Asset Management, L.P. and affiliates have disclosed a 9.7% beneficial ownership stake in Invivyd, Inc., totaling over 20 million shares.

Janus Henderson Group plc and its affiliates have reported a 12.1% beneficial ownership stake in INVIVYD, INC. common stock, held for investment purposes.

Deep Track Capital and related entities report 0% beneficial ownership of Invivyd, Inc. common stock in an amended Schedule 13G filing.

Biotechnology Value Fund and its affiliates have reported a combined beneficial ownership of 7.4% of Invivyd, Inc.'s common stock.

Soleus Capital Management and affiliated entities have reported a 5.1% passive beneficial ownership stake in Invivyd, Inc., totaling 10,850,000 common shares.

Janus Henderson Group plc has reported an 11.6% beneficial ownership stake in INVIVYD, INC., holding over 24 million shares of common stock.

RA Capital Management and its affiliates have disclosed a 9.9% beneficial ownership stake in Invivyd, Inc., totaling 21,338,288 shares.

Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, has disclosed an 8.0% beneficial ownership stake in Invivyd, Inc.

Maverick Capital, Ltd., along with Maverick Capital Management, LLC, and Lee S. Ainslie III, reports beneficial ownership of 8.5% of Invivyd, Inc.'s common stock as of June 30, 2025.

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have jointly disclosed a beneficial ownership of 8.10% in Invivyd, Inc.'s common stock.

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, disclosing a beneficial ownership of 4.8% in INVIVYD INC's common stock as of December 31, 2024.